{"company":{"id":2048099,"name":"Kytopen","domain":"kytopen.com","url":"https://alion.io/company/kytopen"},"section":"news","answer":"Kytopen: 11 headlines on record, 0 headlines in the last 90 days. Its story counts 13 milestones.","figures":[{"label":"Headlines","value":"11"},{"label":"In 90 days","value":"0"},{"label":"Milestones","value":"13"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":10},{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":13}],"news":[{"date":"2026-04-29","kind":"News","title":"Kytopen, T-CURX, and the Fraunhofer IZI Establish Center of Excellence to Develop Advanced, Non-viral Cell Therapies","source":"YahooFinance","url":"https://finance.yahoo.com/sectors/healthcare/articles/kytopen-t-curx-fraunhofer-izi-130000495.html"},{"date":"2026-04-10","kind":"News","title":"Kytopen: Series B Investment To Scale Cell Therapy Manufacturing Platform","source":"Pulse 2.0","url":"https://pulse2.com/kytopen-series-b-investment-to-scale-cell-therapy-manufacturing-platform/"},{"date":"2025-11-12","kind":"News","title":"Kytopen and Excellos Explore New Pathways to Non-Viral Cell Therapy Manufacturing","source":"YahooFinance","url":"https://finance.yahoo.com/news/kytopen-excellos-explore-pathways-non-140000803.html"},{"date":"2025-05-08","kind":"News","title":"Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing","source":"YahooFinance","url":"https://uk.finance.yahoo.com/news/kytopen-bio-techne-collaborate-integrated-133000098.html"},{"date":"2025-04-29","kind":"News","title":"Kytopen and Aldevron Expedite Cell Therapy Manufacturing Through Their Collaborative CRISPR-mediated Cellular Engineering Workflow","source":"YahooFinance","url":"https://uk.finance.yahoo.com/news/kytopen-aldevron-expedite-cell-therapy-140700832.html"},{"date":"2025-04-28","kind":"News","title":"Kytopen Teams Up With Aldevron To Enhance Workflow Solutions For Cell Therapy Developers","source":"Nasdaq","url":"https://nasdaq.com/articles/kytopen-teams-aldevron-enhance-workflow-solutions-cell-therapy-developers"},{"date":"2025-02-13","kind":"News","title":"T-CURX GmbH Enters into Technology Access Agreement with Kytopen","source":"YahooFinance","url":"https://finance.yahoo.com/news/t-curx-gmbh-enters-technology-143000892.html"},{"date":"2024-10-21","kind":"News","title":"Kytopen Enables Significant Advances in Non-viral Cellular Engineering of Monocyte-derived Macrophages","source":"medindia.net","url":"https://medindia.net/health-press-release/kytopen-enables-significant-advances-in-non-viral-cellular-engineering-of-monocyte-derived-macrophages-693703-1.htm"},{"date":"2024-08-13","kind":"Award","title":"Kytopen Receives Prestigious Phase II SBIR Award of $1.6M from the NIAID/NIH to Support Pivotal In Vivo Studies of Engineered Natural Killer Cells","source":"PRNewswire","url":"https://prnewswire.com/news-releases/kytopen-receives-prestigious-phase-ii-sbir-award-of-1-6m-from-the-niaidnih-to-support-pivotal-in-vivo-studies-of-engineered-natural-killer-cells-302220715.html"},{"date":"2023-01-05","kind":"Press release","title":"Kytopen Appoints Paul K. Wotton, Ph.D. to Chair of Board of Directors","source":"The Globe and Mail","url":"https://theglobeandmail.com/investing/markets/stocks/VCEL/pressreleases/13039396/kytopen-appoints-paul-k-wotton-phd-to-chair-of-board-of-directors/"}],"story":[{"title":"Team shrank to 6 was 13 · US Form 5500 (plan participants)"},{"title":"Partnership Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing · YahooFinance","url":"https://uk.finance.yahoo.com/news/kytopen-bio-techne-collaborate-integrated-133000098.html"},{"title":"Partnership Kytopen Teams Up With Aldevron To Enhance Workflow Solutions For Cell Therapy Developers · Nasdaq","url":"https://nasdaq.com/articles/kytopen-teams-aldevron-enhance-workflow-solutions-cell-therapy-developers"},{"title":"Raised a round Venture round $7.1M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1777277/000092963825000827/"},{"title":"Won a grant $1.6M · CORDIS","url":"https://www.sbir.gov/awards?keywords=4R44AI157181-02"},{"title":"Raised a round Convertible Note $5.7M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1777277/000092963824000725/"},{"title":"Board appointment Kytopen Appoints Paul K. Wotton, Ph.D. to Chair of Board of Directors · The Globe and Mail","url":"https://theglobeandmail.com/investing/markets/stocks/VCEL/pressreleases/13039396/kytopen-appoints-paul-k-wotton-phd-to-chair-of-board-of-directors/"},{"title":"Raised a round Series A $32.5M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1777277/000156761921018107/"},{"title":"Won a grant $300k · CORDIS","url":"https://www.sbir.gov/awards?keywords=1R44AI157181-01"},{"title":"Raised a round Venture round $3.1M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1777277/000156761920018874/"},{"title":"Won a grant $948k · CORDIS","url":"https://www.sbir.gov/awards?keywords=1853194"},{"title":"Won a grant $225k · CORDIS","url":"https://www.sbir.gov/awards?keywords=1747096"},{"title":"Founded"}],"as_of":"2026-11-18","cite":"Kytopen, News. Alion, Nov 18, 2026. https://alion.io/company/kytopen/news","html_url":"https://alion.io/company/kytopen/news","json_url":"https://alion.io/company/kytopen/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-18T01:01:03Z"}}